Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Chronic Kidney Disease
NCT00368017Phase 2Terminated
- Sponsor
- Vanderbilt University
- Start
- Apr 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in chronic kidney disease (CKD), sponsored by Vanderbilt University. Started Apr 2006; status: terminated.
02
Drugs
pioglitazone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00368017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368017.